Showing 1 - 10 of 40
This paper studies how patent rights and price regulation affect how fast new drugs are launched in different countries, using newly constructed data on launches of 642 new drugs in 76 countries for the period 1983-2002, and information on the duration and content of patent and price control...
Persistent link: https://www.econbiz.de/10011126137
This paper examines Chevron's programme of CSR at a gas field in Bangladesh. Whilst apparently building partnerships in the villages that surround the Bibiyana Gas Field, we suggest that the corporation remains detached from the local population via their community development programmes and...
Persistent link: https://www.econbiz.de/10010884628
This report presents new evidence relating to the effects of climate policy in Europe, particularly the European Union Emissions Trading Scheme (EU ETS). The evidence is based on new data from almost 800 phone interviews we conducted with managers in manufacturing plants in six European...
Persistent link: https://www.econbiz.de/10011071401
Assessing the value of new medical technologies may require new approaches that take into account a more comprehensive set of parameters than the incremental cost/QALY. It is argued that MCDA can fulfil this role and has the potential to be methodologically superior to the currently used...
Persistent link: https://www.econbiz.de/10010884583
To overcome the problem of insufficient research and development (R&D) on vaccines for diseases concentrated in low-income countries, sponsors could commit to purchase viable vaccines if and when they are developed. One or more sponsors would commit to a minimum price that would be paid per...
Persistent link: https://www.econbiz.de/10011071268
While recent research has explored the phenomenon of drug parallel trade in regulated environments such as the European Union (EU), or the European Economic Area, little is known about the mechanisms that explain its origin or the role of the distribution chain in exporting and importing...
Persistent link: https://www.econbiz.de/10010745350
In the European Union, medicines are regulated products subject to both single market (e.g., regional exhaustion of property rights) and country specific health care regulations (e.g., medicines pricing). This gives rise to parallel trade (PT), a phenomenon that takes place when a patented...
Persistent link: https://www.econbiz.de/10011171762
information on revenues, product and process innovation. I then regress these measures of business performance on top team … between diversity and business performance, which is net positive for process innovation and net negative for turnover …
Persistent link: https://www.econbiz.de/10011125961
interaction among firm-level internationalization, innovation and productivity across seven European countries (Austria, France …-level characteristics across countries and sectors. We also find that the positive correlation between internationalization and innovation … internationalization goes beyond export and because, in the medium to long term, internationalization is likely driven by innovation. We …
Persistent link: https://www.econbiz.de/10011125974
This article analyses the geography of innovation in China and India. Using a tailor-made panel database for regions in … between the provinces and states within both countries are quite different. In China, the concentration of innovation is … contrast, innovation is much more dependent on a combination of good local socioeconomic structures and investment in science …
Persistent link: https://www.econbiz.de/10011125988